Decreased KCC2 activity is linked to the etiology of several neurologic disorders including epilepsy, acute trauma, ischemia, postsurgery complications, and neuropathic pain (Blaesse et al., 2009; Kahle et al., 2013; Medina et al., 2014). Here, SLC12A5 is linked to nervous system disorder.